Add BrightSurf on Google Email

“Molecular bodyguard” helps infections persist

A key molecular player, RfaH, has been identified as a protective shield for bacterial genes, enabling them to survive the hostile environment inside the body. The protein ensures transcription runs to completion, making it an anti-terminator that prevents premature termination of gene expression.

SourceUmea University·JournalmBio·TypeExperimental study·DateOct 9, 2025

UOsaka team with the latest Nobel Prize laureate reveals regulatory immune cell precursors disrupted in severe COVID-19

Researchers at The University of Osaka have identified a previously uncharacterized subset of immune cells called preTfr that play a critical role in preventing autoantibody production. In patients with severe COVID-19, these cells are significantly reduced, correlating with increased levels of harmful autoantibodies.

SourceThe University of Osaka·JournalScience Advances·TypeExperimental study·DateOct 8, 2025

Changes in gut microbiota influence which patients get AIG-related neuroendocrine tumors

Researchers found that specific bacteria, such as Haemophilus parainfluenzae and Fusobacterium species, are associated with AIG-related neuroendocrine tumors. The study suggests that changes in host metabolism occur before alterations in the gastric microbiota, potentially creating a microenvironment that favors tumor growth.

SourceOsaka Metropolitan University·JournalJournal of Gastroenterology·TypeSurvey·DateOct 8, 2025

Researchers find key to stopping deadly infection

New research from Washington University School of Medicine identifies a key step in rotavirus infection and shows that disabling this process can prevent infection. The discovery opens up new avenues for therapeutic intervention, potentially treating not only rotavirus but also other pathogens with similar infection mechanisms.

SourceWashU Medicine·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateOct 7, 2025

POTS common in patients with long COVID

A new study from Karolinska Institutet reveals that postural orthostatic tachycardia syndrome (POTS) affects nearly a third of patients with severe long COVID, with middle-aged women being the most common demographic. Researchers emphasize that POTS can be detected with simple tests and treated to alleviate symptoms.

SourceKarolinska Institutet·JournalCirculation Arrhythmia and Electrophysiology·TypeObservational study·DateOct 3, 2025

NUS Medicine to receive S$2 million grant to boost infectious disease diagnostics across Asia

The NUS Medicine will receive a S$2 million grant from Novo Nordisk Foundation and Temasek Foundation to strengthen microbiology testing for severe bacterial infections across Asia. The DETECT-Asia programme aims to combat antimicrobial resistance, which is driving socio-economic inequity and claiming millions of lives globally.

‘Alarming’ rise in newborn babies with antibiotic-resistant infections, researchers find

A study published in The Lancet Regional Health – Western Pacific found that most newborn infections in Southeast Asia are caused by bacteria unlikely to respond to current treatments, highlighting the need for updated diagnostic and treatment guidelines. Locally relevant data is crucial for guiding routine medical decisions, and new a...

SourceUniversity of Sydney·JournalThe Lancet Regional Health - Western Pacific·TypeObservational study·DateSep 29, 2025

Olfactory dysfunction after SARS-CoV-2 infection

A cohort study investigated olfactory dysfunction in US adults with and without prior SARS-CoV-2 infection. The study found a significant association between prior infection and persistent olfactory dysfunction. High variability was observed among individuals, highlighting the need for individualized assessment and treatment strategies.

SourceJAMA Network·JournalJAMA Network Open·DateSep 25, 2025

In pregnant mice with severe flu, harmful molecules can breach fetal barriers

A new study from the University of Illinois shows that severe flu infection in pregnant mice leads to a breakdown in placental and brain barriers, allowing potentially harmful molecules to accumulate in the fetal brain. Fibrinogen accumulation has also been linked to neuroinflammatory conditions, and researchers found it accumulated in...

Groundbreaking AI aims to speed lifesaving therapies

A new open-source AI tool, ProRNA3D-single, has significantly increased accuracy in predicting and visualizing protein-RNA complex structures. This method can generate finely detailed images of molecules in 3D, enabling drug developers to design treatments by analyzing where viruses attach to human proteins.

SourceVirginia Tech·JournalCell Systems·DateSep 16, 2025

From Miami to Berlin: a stowaway rat reveals hidden global health risks

A rat discovered on a flight from Miami to Berlin revealed hidden global health risks, including the presence of a methicillin-susceptible Staphylococcus aureus strain nearly identical to human variants. The study highlights the importance of standardized pathogen screening for animal stowaways and rats as indicators of ecosystem health.

SourceGerman Center for Infection Research·JournalScientific Reports·TypeExperimental study·DateSep 10, 2025

Even healthy children can be severely affected by RSV

A comprehensive registry study in Sweden found that healthy, full-term babies under three months old are at risk of severe illness from RSV. The study highlights several risk factors, including birth weight and sibling age, which increase the risk of needing intensive care or dying.

SourceKarolinska Institutet·JournalThe Lancet Regional Health - Europe·TypeObservational study·DateSep 9, 2025

One dose of penicillin is as effective as standard three doses in treating early syphilis, according to UAB-led study

Researchers at UAB have published a study suggesting one dose of benzathine penicillin G is as effective as the three-injection regimen at treating early syphilis. The study found that one dose is sufficient to treat patients, reducing time and inconvenience associated with multiple injections.

SourceUniversity of Alabama at Birmingham·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateSep 4, 2025

High-volume antibody testing platform could accelerate disease research and treatment development

Researchers developed a high-volume method to rapidly build and test large numbers of antibodies at once, accelerating antibody research and treatment development. The oPool+ display platform has potential applications in influenza vaccination research, infectious disease treatment, and cancer research.

SourceUniversity of Illinois at Urbana-Champaign, News Bureau·JournalScience Translational Medicine·TypeExperimental study·DateSep 3, 2025

Myocardial infarction may be an infectious disease

Researchers discovered that atherosclerotic plaques contain gelatinous biofilms formed by bacteria, which can trigger inflammation and rupture of the plaque leading to myocardial infarction. The study also validated an antibody targeting these bacteria, suggesting new diagnostic and therapeutic strategies for myocardial infarction.

SourceTampere University·JournalJournal of the American Heart Association·DateAug 27, 2025

Generative AI uncovers undetected bird flu exposure risks in Maryland emergency departments

A new study uses generative AI to quickly scan notes in electronic medical records and identify high-risk patients with potential H5N1 avian influenza exposure. The model detected 76 patients with high-risk exposures, including 14 confirmed cases of recent bird flu exposure.

SourceUniversity of Maryland School of Medicine·JournalClinical Infectious Diseases·TypeData/statistical analysis·DateAug 25, 2025

Mount Sinai creates first manual for treating infection-associated chronic illness for clinicians

The Mount Sinai Hospital has launched the country's first clinical manual for treating infection-associated chronic illnesses (IACIs), a comprehensive guide for diagnosis and care. The manual covers extensive learnings from the Cohen Center and provides practical strategies for clinicians to support patients with conditions such as lon...

Brain Network Disorders Review explores biomarkers linked to rare autoimmune brain disease

Researchers identify key symptom categories and biomarkers for anti-NMDAR encephalitis, a rare autoimmune brain condition. Clinical manifestations suggest the presence of anti-NMDAR encephalitis through NMDA antibody checks, uric acid levels, C-reactive protein, and thyroid-related hormones.

SourceBrain Network Disorders Editorial Office·JournalBrain Network Disorders·TypeLiterature review·DateAug 8, 2025